Steris (STE) Common Equity (2017 - 2026)

Steris has reported Common Equity for 10 years, with the latest figure at $7.2 billion in Q2 2026.

• On a quarterly basis, Common Equity rose 3.61% year-over-year to $7.2 billion in Q2 2026; TTM through Jun 2026 was $7.2 billion, a 3.61% increase from a year earlier, with the FY2026 full-year figure at $7.2 billion, up 8.79% from the prior year.
• Common Equity was $7.2 billion for Q2 2026 at Steris, roughly flat from $7.2 billion in the prior quarter.
• The five-year high for Common Equity was $7.2 billion in Q2 2026, with the low at $5.8 billion in Q3 2022.
• Average Common Equity over 5 years is $6.5 billion, with a median of $6.4 billion recorded in 2023.
• The largest YoY upside for Common Equity was 68.18% in 2022 against a maximum downside of 11.18% in 2022.
• Over 5 years, Common Equity stood at $6.0 billion in 2022, then gained by 6.28% to $6.4 billion in 2023, then gained by 0.01% to $6.4 billion in 2024, then climbed by 11.5% to $7.2 billion in 2025, then climbed by 0.74% to $7.2 billion in 2026.
• The last three Common Equity figures came in at $7.2 billion (Q2 2026), $7.2 billion (Q1 2026), and $7.2 billion (Q4 2025), per Business Quant data.